Otolaryngology Doctors in Ypsilanti, MI Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Joseph Morgan Seymour, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Rm 2017, Ypsilanti, MI 48197 Phone: 734-434-3200    Fax: 734-434-3209

Dr. Ronald S Bogdasarian, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5333 Mcauley Dr, Suite 2017, Ypsilanti, MI 48197 Phone: 734-434-3200    Fax: 734-434-3209

Dr. Laurence Ho, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 2017, Ypsilanti, MI 48197 Phone: 734-434-3200    Fax: 734-434-3209

Dr. Thomas A Weimert, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5333 Mcauley Dr, Rm 2017, Ypsilanti, MI 48197 Phone: 734-434-3200    Fax: 734-434-3209

Henry Alexander Arts, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 5333 Mcauley Dr Rm 2017, Ypsilanti, MI 48197 Phone: 734-434-3200

News Archive

University of Louisville researchers take a step forward in battle against lung cancer

Researchers at the University of Louisville have uncovered a cadre of small molecules that tell certain proteins to kill lung cancer cells. The team, led by Chi Li, Ph.D., assistant professor of medicine, published its finding in the April 2014 issue of Molecular and Cellular Biology.

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.

Study examines drug resistance in ALK positive lung cancer

Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer. It's the first time scientists have analyzed the frequency and type of drug resistance in ALK positive patients taking crizotinib.

Scientists discover how to make human collagen in the lab

It is the most important structural protein in the body, reinforcing connective tissue, bones and teeth, and forming long, fibrous cables to strengthen tendons. Collagen forms sheets of tissue that support the skin and every internal organ.

Read more Medical News

› Verified 6 days ago